EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

期刊官网投稿通道

提出问题

友情提示：以下期刊信息可能会有更新，仅供参考，请在投稿前自行登录期刊官网仔细核实。

期刊名

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

EUR J MED CHEM

ISSN / eISSN

0223-5234 / 1768-3254

目标和范围

The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers.

A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.

研究方向

药物化学

CiteScore

12.10

查看趋势图

CiteScore 学科排名

类别	分区	排名
Chemistry - Organic Chemistry	Q1	#10/197
Chemistry - Pharmacology	Q1	#22/301
Chemistry - Drug Discovery	Q1	#14/156

Web of Science 核心合集

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

类别 (Journal Citation Reports 2023)	分区
CHEMISTRY, MEDICINAL - SCIE	Q1

H-index

135

出版国家或地区

FRANCE

出版商

Elsevier Masson SAS

出版周期

Monthly

年文章数

866

Open Access

通讯方式

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 23 RUE LINOIS, PARIS, FRANCE, 75724

同领域相关热门期刊
近期发表文章

Synthesis and clinical application of small-molecule drugs approved to treat prostatic cancer: (2023) Jing-Yi Zhang, Li-Jie Zhao, Ya-Tao Wang

Discovery of benzamide-based PI3K/HDAC dual inhibitors with marked pro-apoptosis activity in lymphoma cells: (2023) Jingjing Deng, Baogeng Hou, Xiaohan Hou, Yuxin Chen, Tao Zhang, Hua Chen, Yuanze Wang, Xiaoyang Li

Unlocking the synthetic approaches and clinical application of approved small-molecule drugs for gastrointestinal cancer treatment: A comprehensive exploration: (2023) Xiao-Jing Li, Peng Nie, Piet Herdewijn, Jian-Gang Sun

Discovery of 4-hydroxyl pyrazole derivatives as potent ferroptosis inhibitors: (2023) Ying Danzhi, Xin Shen, Shuqi Wang, Junyi Chen, Zhenying Wu, Wenteng Chen, Fudi Wang, Junxia Min, Yongping Yu

Design, synthesis, ADME and biological evaluation of benzylpiperidine and benzylpiperazine derivatives as novel reversible monoacylglycerol lipase (MAGL) inhibitors: (2023) Miriana Di Stefano, Samuele Masoni, Giulia Bononi, Giulio Poli, Salvatore Galati, Francesca Gado, Simone Manzi, Chiara Vagaggini, Annalaura Brai, Isab...

Discovery of proteolysis-targeting chimera targeting undruggable proteins using a covalent ligand screening approach: (2023) Hyeonjun Lee, Ju Yeon Lee, Hyunsoo Jang, Hye Young Cho, Minhee Kang, Sang Hyun Bae, Suin Kim, Eunji Kim, Jaebong Jang, Jin Young Kim, Young Ho Jeon

Novel family of [RuCp(N,N)(P)]+ compounds with simultaneous anticancer and antibacterial activity: Biological evaluation and solution chemistry studies: (2023) Ricardo G. Teixeira, János P. Mészáros, Beatriz Matos, Leonor Côrte-Real, Cristina P.R. Xavier, Xavier Fontrodona, M. Helena Garcia, Isabel Romero, Ga...

Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors: (2023) Aijia Wu, Kunyu Shi, Jiaxing Wang, Ruofei Zhang, Yuxi Wang

Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection: (2023) Shuang Mei, Yunting Zou, Su Jiang, Lu Xue, Yuting Wang, Han Jing, Peng Yang, Miao-Miao Niu, Jindong Li, Kai Yuan, Yan Zhang

Design and synthesis of etrasimod derivatives as potent antibacterial agents against gram-positive bacteria: (2023) Matej Zore, Paola San-Martin-Galindo, Inés Reigada, Leena Hanski, Adyary Fallarero, Jari Yli-Kauhaluoma, Jayendra Z. Patel

认证评论

注：认证评论选取于全球各个学术评论平台和社交媒体。

Summary article submitted in early June, got a response within three days but not a direct rejection. The editor provided suggestions for modifications and gave a month to integrate the content. At the end of the month, it was resubmitted and placed under review. However, it took a long time for the reviewer to be found, resulting in a review period of almost three months. After receiving the reviewer's comments, the editor requested major revisions, and after the modifications were made, the article was accepted directly.

2023-01-02

I submitted the article at the beginning of August, and by the end of August, I received feedback for revision from the first review. The review process was quick, and both the editor and the reviewer were very nice, suggesting only minor revisions. After submitting the revised version in early September, I received acceptance notification within about a week. Overall, the process went smoothly, and this journal's influence in the field of pharmacy is increasing. I hope it continues to improve.

2022-09-15

查看所有评论

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started